Analgesic 1-oxa-, aza- and thia-spirocyclic compounds

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

260/306, 260/329

C07D 307/94 (2006.01) C07C 29/20 (2006.01) C07C 33/14 (2006.01) C07C 43/315 (2006.01) C07D 209/54 (2006.01) C07D 317/72 (2006.01) C07D 333/50 (2006.01) C07D 405/02 (2006.01) C07D 409/04 (2006.01) C07D 493/10 (2006.01)

Patent

CA 1187082

ABSTRACT Mono-Oxa-, thiaspirocyclic-benzene-acetamide and -benzamide compounds of the formula Image (I) wherein p, n, m, A, E, R, R1, R2, X, Y and Z are as defined in the specification, e.g., (?)-(5.alpha.,7.alpha.,8.beta.)-3,4-dichloro-N-methyl-N-[7-(1- pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]benzeneacetamide, and the phar- macologically acceptable salts thereof, are useful as analgesic com- pounds having low physical dependence liability, compared to morphine and methodone, and low dysphoria side effects. Some of these com- pounds have potent analgesic activity when administered orally, and some have low CNS sedative side effects. Pharmaceutical compositions and methods for using these compounds as analgesics are disclosed. Processes for preparing this class of compounds are also disclosed.

412863

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Analgesic 1-oxa-, aza- and thia-spirocyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Analgesic 1-oxa-, aza- and thia-spirocyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Analgesic 1-oxa-, aza- and thia-spirocyclic compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1185664

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.